Vina Churdboonchart
Corporate Officer/Principal presso Mahidol University
Profilo
Dr. Vina Churdboonchart is President at Trinity Medical Group, Inc. and a Member at Mahidol University.
Posizioni attive di Vina Churdboonchart
Società | Posizione | Inizio |
---|---|---|
Mahidol University | Corporate Officer/Principal | 25/02/2010 |
Precedenti posizioni note di Vina Churdboonchart
Società | Posizione | Fine |
---|---|---|
Trinity Medical Group, Inc.
Trinity Medical Group, Inc. Miscellaneous Commercial ServicesCommercial Services Trinity Medical Group, Inc. markets HIV-Immunogen also known as REMUNE, a patented therapeutic vaccine treatment, designed to induce specific T cell responses in people infected with the Human Immunodeficiency Virus. REMUNE is an immune-based therapy consisting of whole inactivated HIV-1 virus depleted of its gp120 coat protein based on Dr. Jonas Salk's vaccine technology. The company was founded on September 28, 1998 and is headquartered in Las Vegas, NV. | Fondatore | 25/02/2010 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Trinity Medical Group, Inc.
Trinity Medical Group, Inc. Miscellaneous Commercial ServicesCommercial Services Trinity Medical Group, Inc. markets HIV-Immunogen also known as REMUNE, a patented therapeutic vaccine treatment, designed to induce specific T cell responses in people infected with the Human Immunodeficiency Virus. REMUNE is an immune-based therapy consisting of whole inactivated HIV-1 virus depleted of its gp120 coat protein based on Dr. Jonas Salk's vaccine technology. The company was founded on September 28, 1998 and is headquartered in Las Vegas, NV. | Commercial Services |
- Borsa valori
- Insiders
- Vina Churdboonchart